Umeå University

    Foundation year1992
    DirectorProf. Peter M. Andersen
    Principal investigatorProf. Peter M. Andersen, Prof. Stefan Marklund, Prof. Thomas Brännström

    The ALS research group at Umeå University performs genetic, SOD1, proteomic and metabolomic research, as well as iPS research. The mail focus has become studying misfolding properties of mutant and non-mutant SOD1 and the formation of misfolded SOD1 species in human tissues as well as in tg-mice. The group is also involved in two JPND projects NEEDS in ALS and ONWEBDUALS. In 2017 the group consists of approx. 18 researchers and 12 technicians and research nurses. The ALS Clinical Center was established in 1992 at Umeå University Hospital (“NUS”) and is the principal center for diagnosing and caring of patients with neuromuscular diseases in northern Sweden. The clinical team also performs second-opinion evaluations of patients from other parts of Sweden and from abroad.

    Contact Information

    AddressUmeåAnalysvägenSE-901 85 Sweden

    Restricted information

    Serving population
    Primarily Sweden

    Patient resources

    Population based register
    Clinic based register
    Geographically matched controles
    Number of muscle samples
    0
    Number of skin samples
    80
    Number of spinal cord samples
    0
    Number of brain samples
    0
    Number of IPS cell samples
    0

    Banks

    TypeALS PatientsControlsOther
    DNA bank
    2800
    -
    9200
    CSF
    350
    -
    -

    Research activities

    Clinical management research
    Neuro epidemiology
    Neuro physiology
    Neuro imaging
    Neuro psychology
    Neuro pathology
    Genomics
    Transcriptomics
    Metabolomics

    Publication

    • Comprehensive mutational analysis to explain reduced or increased SOD1 enzymatic activity in erythrocystes from ALS patients and their relatives. Keskin I, Birve A, Berdynski M, Hjertkvist K, Rofougaran R, Nilsson TK, Marklund SL, Andersen PM. Amytrophic lateral sclerosis & Fronto-temporal degeneration. In press February 2017.
    • Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-prime PCR interpretation: A large multinational screening study. Nordin A, Akimoto C, Wuolikainen, Nordin A, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A-M, Ludolph AC, Weishaupt J, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirt C, Holme T, Morita M, Tysnes O-B, Benatar M, Wuu J, Lange D, Bisgård C, Asgari N, Tarvainen I, Brännström T, Andersen PM. Amyotroph Lateral Scler Frontotemporal Degener 2016 (Epub ahead of print December 12, 2016).
    • Pre-symptomatic ALS Genetic Counseling and testing: Experience and recommendations. Benatar M, Stanislaw C, Reyes E, Hussain S, Cooley A, Fernandez MC, Dauphin D, Michon A-C, Andersen PM, Wuu J. Neurology 2016;86:2295-302.
    • Inoculated SOD1 aggregate strain transmits amyotrophic lateral sclerosis with templated aggregation. Bidhendi EE, Bergh J, Zetterström P, Andersen PM, Marklund SL, Brännström T. J Clin Invest. 2016;126:2249-53.
    • Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. Bidhendi EE, Bergh J, Zetterström P, Andersen PM, Marklund SL, Brännström T. J Clin Invest. 2016 Jun 1;126(6):2249-53. doi: 10.1172/JCI84360. PMID: 27140399.

    For more publications, see PubMed.